HeartSciences (HSCS) Enterprise Value (2022 - 2026)
HeartSciences (HSCS) posted quarterly Enterprise Value of -$1.7 million for Q2 2026, down 54.55% year-on-year from -$3.7 million in Q2 2025, and down 54.81% on a QoQ basis from -$1.1 million in Q4 2025.
HeartSciences (HSCS) Enterprise Value (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Enterprise Value for 5 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.
- Quarterly Enterprise Value fell 54.55% year-over-year to -$1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$1.7 million (down 54.55% YoY) and the FY2026 annual result came in at -$1.7 million, down 54.55% from the prior year.
- Enterprise Value declined to -$1.7 million in Q2 2026 per HSCS's latest filing, from -$1.1 million in the prior quarter.
- Over the last five years, Enterprise Value for HSCS reached as high as -$100144.0 in Q4 2023 and fell as low as -$7.1 million in Q1 2024.
- A 5-year average of -$2.7 million and a median of -$2.0 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value surged 96.74% — and 2024, when it plunged 3946.29%.
- Year by year, Enterprise Value stood at -$3.1 million in 2022, then jumped by 96.74% to -$100144.0 in 2023, then tumbled by 3946.29% to -$4.1 million in 2024, then soared by 72.9% to -$1.1 million in 2025, then sank by 54.81% to -$1.7 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$1.7 million, -$1.1 million, and -$2.0 million for Q2 2026, Q4 2025, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | -3.09 Bn |
| 10 | HeartSciences | 6.64 Mn | 4.94 Mn | - | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.70 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Oct 31, 2025 | -1.95 Mn |
| Jul 31, 2025 | -2.79 Mn |
| Apr 30, 2025 | -1.10 Mn |
| Jan 31, 2025 | -2.60 Mn |
| Oct 31, 2024 | -4.05 Mn |
| Jul 31, 2024 | -4.34 Mn |
| Apr 30, 2024 | -5.81 Mn |
| Jan 31, 2024 | -7.08 Mn |
| Oct 31, 2023 | -100,144.00 |
| Jul 31, 2023 | -575,654.00 |
| Apr 30, 2023 | -1.70 Mn |
| Jan 31, 2023 | -1.93 Mn |
| Oct 31, 2022 | -3.08 Mn |
| Jul 31, 2022 | -4.27 Mn |
| Apr 30, 2022 | -918,260.00 |